<DOC>
	<DOCNO>NCT01443598</DOCNO>
	<brief_summary>HYPID study observational prospective study patient interstitial lung disease pre capillary hypertension diagnose right heart side catheterization . The primary aim study identify prognostic factor .</brief_summary>
	<brief_title>Pulmonary Hypertension Interstitial Lung Disease</brief_title>
	<detailed_description>Pre capillary pulmonary hypertension ( PH ) may present patient diffuse interstitial lung disease . In context , PH represent important factor morbidity mortality patient . One purpose HYPID determine predictive factor mortality within cohort patient . In order reach aim , study include evaluation base exams conduct routine follow-up patient . Each patient follow 2 year least .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<criteria>pre capillary pulmonary hypertension right heart side catheterization : mPAP &gt; = 25 mmHg , PCWP &lt; = 15 mmHg interstitial lung disease diffuse infiltrative opacity chest CT scan pulmonary hypertension relate thromboembolic disease respiratory disease diffuse interstitial lung disease etiological factor pulmonary arterial hypertension base DANA POINT classification diffuse interstitial lung disease progressive disease associate life expectancy le 6 month pulmonary hypertension , diffuse interstitial lung disease respiratory insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Pulmonary arterial hypertension ,</keyword>
	<keyword>Interstitial lung disease HRCT</keyword>
</DOC>